Information Journal Paper
APA:
CopyMOUSAVI ARDEHAIE, R.. (2017). ABERRANT METHYLATED EDNRB CAN ACT AS A POTENTIAL DIAGNOSTIC BIOMARKER IN SPORADIC COLORECTAL CANCER WHILE KISS1 IS CONTROVERSIAL. BIOENGINEERED, 8(5), 555-564. SID. https://sid.ir/paper/713197/en
Vancouver:
CopyMOUSAVI ARDEHAIE R.. ABERRANT METHYLATED EDNRB CAN ACT AS A POTENTIAL DIAGNOSTIC BIOMARKER IN SPORADIC COLORECTAL CANCER WHILE KISS1 IS CONTROVERSIAL. BIOENGINEERED[Internet]. 2017;8(5):555-564. Available from: https://sid.ir/paper/713197/en
IEEE:
CopyR. MOUSAVI ARDEHAIE, “ABERRANT METHYLATED EDNRB CAN ACT AS A POTENTIAL DIAGNOSTIC BIOMARKER IN SPORADIC COLORECTAL CANCER WHILE KISS1 IS CONTROVERSIAL,” BIOENGINEERED, vol. 8, no. 5, pp. 555–564, 2017, [Online]. Available: https://sid.ir/paper/713197/en